These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. BURNS JJ; YU TF; RITTERBAND A; PEREL JM; GUTMAN AB; BRODIE BB J Pharmacol Exp Ther; 1957 Mar; 119(3):418-26. PubMed ID: 13417097 [No Abstract] [Full Text] [Related]
4. [On the determination of uricosuric activity in the rat]. Coppi G; Bonardi G Boll Soc Ital Biol Sper; 1965 Jul; 41(13):712-3. PubMed ID: 5876561 [No Abstract] [Full Text] [Related]
5. [On the uricosuric effect of a sulfoxide analogue of phenylbutazone]. JUNGBLUTH H; MARTIN H Chemotherapia (Basel); 1961; 3():487-94. PubMed ID: 14452809 [No Abstract] [Full Text] [Related]
6. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). MONTGOMERY DB; OGRYZLO MA Can Med Assoc J; 1960 Oct; 83(17):885-8. PubMed ID: 13772195 [No Abstract] [Full Text] [Related]
7. The influence of probenecid, phenylbutazone and salicylates upon urate excretion in man. SIROTA JH Rheumatism; 1957 Oct; 13(4):93-100. PubMed ID: 13477859 [No Abstract] [Full Text] [Related]
8. [EFFECT OF PHENYLBUTAZONE ON THE URICEMIA OF SUBJECTS TREATED WITH CHLOROTHIAZIDE]. MORDEGLIA F; BASTAROLI J; FERNANDEZGARCIA E Sem Med; 1963 Jun; 122():1506-7. PubMed ID: 14070550 [No Abstract] [Full Text] [Related]
9. [The antirheumatic value of phenylbutazone]. KELLY M Arch Interam Rheumatol; 1962 Sep; 5():438-50. PubMed ID: 14031828 [No Abstract] [Full Text] [Related]
10. [Effect of antirheumatic agents on the autoimmune reaction in vitro]. Sachkov VI; Ponomareva AG Farmakol Toksikol; 1971; 34(1):77-9. PubMed ID: 5314949 [No Abstract] [Full Text] [Related]
15. [Therapeutic experiences with the antirheumatic agent delta-butazolidine at the rheumatology center of Koeflach]. REISENHOFER A Wien Med Wochenschr; 1961 Apr; 111():245-7. PubMed ID: 13740654 [No Abstract] [Full Text] [Related]
16. [Research on the therapeutic activity and tolerance of a new antirheumatic drug (1,4-diphenyl-3, 5-pyrazolidinedione aminophenazone)]. CAGIANELLI MA; PANESI M Minerva Med; 1957 May; 48(37 Suppl):1659-82. PubMed ID: 13451348 [No Abstract] [Full Text] [Related]
17. [Phenylbutazone in various rheumatic diseases]. COSSERMELLI W; GIANNINI SG; SPILBORGHS G Rev Assoc Med Bras; 1956 Sep; 2(4):341-4. PubMed ID: 13389893 [No Abstract] [Full Text] [Related]
18. [Phenylbutazone in rheumatic diseases]. FRANCE O; LOSADA M Rev Med Chil; 1957 Dec; 85(12):725-30. PubMed ID: 13528121 [No Abstract] [Full Text] [Related]
19. [Results obtained with the use of phenylbutazone in patients with various rheumatic diseases]. GAMARSKI J Med Cir Farm; 1958 Dec; 20(272):575-83. PubMed ID: 13621959 [No Abstract] [Full Text] [Related]
20. Considerations on 130 cases of rheumatic diseases treated with phenylbutazone. STOIA I; NITESCU S; GRUNWALD L; LEIBOVICI S Rum Med Rev; 1957; 1(3):37-41. PubMed ID: 13528876 [No Abstract] [Full Text] [Related] [Next] [New Search]